Showing results (11-20 of 34) with videos related to
Sort By:
Pageof 4
Cancer Biology & Medicine|January 17, 2023
Targeted mechanical forces enhance the effects of tumor immunotherapy by regulating immune cells in the tumor microenvironmentPengfei Zhu, Hongrui Lu, Mingxing Wang, et al.Cancer Letters|March 28, 2025
Anticancer therapy-induced peripheral neuropathy in solid tumors: diagnosis, mechanisms, and treatment strategiesJiahong Jiang, Luying Zhan, Boyang Jiang, et al.American Journal of Cancer Research|June 11, 2024
Unraveling role of ubiquitination in drug resistance of gynecological cancerLi Yu, Zheling Chen, Ying Wu, et al.Frontiers in Pharmacology|August 9, 2020
Apatinib Combined With SOX Regimen in Conversion Treatment of Advanced Gastric Cancer: A Case Series and Literature ReviewDingyi Jiang, Yunyun Xu, Yunwang Chen, et al.Oncotarget|April 15, 2017
Loss of PTEN expression in breast cancer: association with clinicopathological characteristics and prognosisShuting Li, Yanwei Shen, Mengying Wang, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 17, 2016
Potential biomarkers for anti-EGFR therapy in metastatic colorectal cancerJiao Yang, Shuting Li, Biyuan Wang, et al.Plos One|June 24, 2017
Tumor location as a novel high risk parameter for stage II colorectal cancersBiyuan Wang, Jiao Yang, Shuting Li, et al.International Journal of Biological Sciences|June 29, 2017
Angiomotin Family Members: Oncogenes or Tumor Suppressors?Meng Lv, Yanwei Shen, Jiao Yang, et al.Surgical Endoscopy|July 19, 2019
Laparoscopic pancreaticoduodenectomy versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: oncologic outcomes and long-term survivalKe Chen, Yucheng Zhou, Weiwei Jin, et al.Frontiers in Pharmacology|October 29, 2020
Conversion Therapy for Advanced Pancreatic Cancer: The Case Series and Literature ReviewMingxing Wang, Yunyun Xu, Min Yang, et al.Pageof 4